AQST

Aquestive Therapeutics
$3.73
+$0.05 (+1.36%)Jul 27, 2026
2.8FairMoatMint rating

MoatMint rates Aquestive Therapeutics (AQST) 2.8 out of 10, a research rating of the company's quality, value, growth, momentum and financial health. Its quality rating is 1.5 out of 10.

Key metrics

The numbers that frame AQST today
Market cap
$467.93M
P/E (TTM)
-6.8
EV / FCF
-11.1
Gross margin
63.5%
EV / Sales
9.8
ROIC
-39.5%
Div yield
0%
52wk Low
$2.93
52wk High
$7.55

AQST stock rating

How AQST scores on quality, value, growth, momentum and financial health
2.8out of 10
Fair overallHealthy business, expensive priceTop 72% of ~5,000 US stocks
QualityPoor1.5/10
GrowthGreat9.3/10
MomentumNeutral5.8/10
ValueFair2.2/10
Financial HealthPoor1.7/10

Growth

Revenue and earnings trend for AQST
RevenueNet income
See the full growth breakdown

Revenue and earnings trends, margins and the multi-year trajectory - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Cash flow & returns

Free cash flow and financial health
Free cash flowNet debt
See the full cash-flow picture

Free cash flow detail, returns on capital and the balance-sheet trend - free with an account.

Create a free account
Free foreverNo card required
Already a member? Log in

Insider trading

Recent insider buying and selling activity
PurchasesSales
Unlock every insider trade

See who is buying and selling, how much, and when - updated as new filings land.

Create a free account
Free foreverNo card required
Already a member? Log in

Frequently asked questions

Plain-English answers about AQST
Is Aquestive Therapeutics a good buy?
No. Aquestive Therapeutics has poor quality and mixed momentum. The setup is weak overall. Growth looks excellent, which supports the long-term business case, but that is not enough to offset the weak setup. We think Aquestive Therapeutics is selling at a very high price.
What is the market capitalization of AQST?
Aquestive Therapeutics's market capitalization is $467.93M.
What is the P/E ratio for AQST stock?
Aquestive Therapeutics's current P/E ratio is -6.8.
What is the 52-week high for AQST stock?
The 52-week high for Aquestive Therapeutics is $7.55. The current close of $3.73 is 50.6% below that high.
What is the 52-week low for AQST stock?
The 52-week low for Aquestive Therapeutics is $2.93. The current close of $3.73 is 27.3% above that low.
Does AQST stock pay dividends?
Aquestive Therapeutics does not currently show a dividend per share in the company data.